| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1639296-49-3 | 6-Bromo-5-chlorobenzo[b]thiophene-2-carboxylic acid methyl ester | C10H6BrClO2S |
| 1639324-58-5 | Cemdisiran | C78H140N11O34P |
| 1639325-43-1 | Givosiran | C78H139N11O30 |
| 1639351-92-0 | Mc-Val-Cit-PAB-Cl | C28H39ClN6O6 |
| 1639454-74-2 | trans-2-((tert-Butoxycarbonyl)amino)-1-fluorocyclobutane-1-carboxylicacid | C10H16FNO4 |
| 1639454-84-4 | (1R,2R)-2-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclobutane-1-carboxylic acid | C10H16FNO4 |
| 1639866-72-0 | 3-Amino-5-ethynylbenzoic acid | C9H7NO2 |
| 1639970-62-9 | Sacubitril Impurity 57 | C22H23NO4 |
| 1640282-31-0 | 1-[7-(3,4-Dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]-1-propanone | C27H36N2O5 |
| 1640292-55-2 | trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide (2Z)-2-butenedioate (1:1) | C15H23N5O2S.C4H4O4 |
| 1640971-87-4 | Tofacitinib Related Compound 2 HCl | C10H18ClN3O |
| 1640972-35-5 | Tofacitinib Impurity | C16H22N6O |
| 1640981-19-6 | 4-Hydroxy-2-methyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxylic acid | C16H14N2O3 |
| 1642288-47-8 | Mavacamten | C15H19N3O2 |
| 1642298-59-6 | 3-(Fluoromethyl)azetidine hydrochloride | C4H9ClFN |
| 1642303-38-5 | Lenrispodun phosphate | C29H29FN7O5P |
| 1642306-14-6 | Otophylloside T | C48H70O18 |
| 1642308-34-6 | 2,6-Bis[4-(9H-carbazol-9-yl)phenyl]-9,10-anthracenedione | C50H30N2O2 |
| 1642330-72-0 | 2-(Biphenyl-4-yl)-4-(4-chlorophenyl)-6-phenyl-1,3,5-triazine | C27H18ClN3 |
| 1642330-94-6 | Rosuvastatin Impurity 41 | C15H26O6 |
| 1642542-05-9 | 1-Bromo-5-chloro-3-fluoro-2-nitrobenzene | C6H2BrClFNO2 |
| 1642571-08-1 | tert-Butyl (S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate | C27H30N6O3 |
| 1642630-12-3 | 3-(4-Phenoxyphenyl)-1-(3S)-3-piperidinyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C22H22N6O |
| 1642853-67-5 | N-[(2,3-Dihydro-1-methyl-2-oxo-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C19H20N4O4 |
| 1642873-03-7 | N-Propylsulfamide sodium salt | C3H9N2O2SNa |
| 1643141-20-1 | 1-Methyl-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile hydrochloride (1:1) | C7H10N4.HCl |
| 1643156-18-6 | 4-Bromo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride | C7H6BrFN2O2.HCl |
| 1643330-62-4 | 5-Chloro-N-[4-[5,6-dihydro-3-(4-morpholinyl)-2-oxo-1(2H)-pyridinyl]phenyl]pentanamide | C20H26ClN3O3 |
| 1643377-48-3 | 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-N-(3-amino-3-oxopropyl)-1-methyl-N-2-pyridinyl-1H-benzimidazole-5-carboxamide | C25H26N8O2 |
| 1643378-47-5 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(4-Fluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | C23H29FN6O4S |
| 1643378-48-6 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(2,3-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | C23H28F2N6O4S |
| 1643479-47-3 | 9-[1,1'-Biphenyl]-3-yl-9'-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole | C48H32N2 |
| 1643526-99-1 | 3-([1,1'-Biphenyl]-3-yl)-9H-carbazole | C24H17N |
| 1643678-96-9 | 9-(4-Dibenzofuranyl)-9H-fluoren-9-ol | C25H16O2 |
| 1643684-05-2 | Atomoxetine EP Impurity D | C17H21NO .HCl |
| 1643684-06-3 | Atomoxetine EP Impurity C | C17H22ClNO |
| 1643848-13-8 | 4-(2-Benzoxazolyl)-N-phenylbenzenamine | C19H14N2O |
| 1643913-93-2 | (2E)-3-(6-Amino-3-pyridinyl)-N-[[5-[4-[(4,4-difluoro-1-piperidinyl)carbonyl]phenyl]-7-(4-fluorophenyl)-2-benzofuranyl]methyl]-2-propenamide | C35H29F3N4O3 |
| 1644054-07-8 | N-(9,9-dimethyl-9H-fluoren-4-yl)-9,9-dimethyl-9H-fluoren-2-amine | C30H27N |
| 1644286-34-9 | Pemetrexed EP impurity B & C mixture (1:1) | C40H40N10O13 |
| 1644287-27-3 | N-[4-[2-(2-Amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid | C20H21N5O7 |
| 1644295-07-7 | 3-[[[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]amino]carbonyl]-bicyclo[2.2.1]heptane-2-carboxylic acid | C28H38N4O3S |
| 1644457-28-2 | (5S)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine | C13H20N2 |
| 1644457-29-3 | [(7S)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone | C23H27N5O |
| 1644461-85-7 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylsulfinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | C23H28F2N6O5S |
| 1644466-71-6 | 2-(9,9-Diphenyl-9H-fluoren-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C31H29BO2 |
| 1644545-52-7 | 6-(6-Chloro-2-pyridinyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methylethyl]-1,3,5-triazine-2,4-diamine | C14H13ClF6N6 |
| 1644548-81-1 | Methyl 6-(trifluoromethyl)pyrazine-2-carboxylate | C7H5F3N2O2 |
| 1644667-44-6 | (±)-Benzyl 2-(4-Cyanophenyl)-4-Oxo -3,4-Dihydropyridine-1(2H)-Carboxylate | C20H16N2O3 |
| 1644667-45-7 | (±)-benzyl 2-(4-cyanophenyl)-4-oxopiperidine-1-carboxylate | C20H18N2O3 |